4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...

4/26/2025Recent Executive Moves

4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...

4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...

4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...

4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma

4/25/2025Akeso's Ivonescimab Gains Second Approval in China

4/24/2025Bayer Pharma Accelerates Growth in China with Breakthru Therapies and ...

4/24/2025Merck's Gardasil Sales Plunge Amid China Market Turbulence

4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...

4/24/2025US Capital Crunch Pushes China Biotechs to Roundabout Financings (Phar...

4/24/2025China Biopharma Tracker – March 2025 (PharmaDJ)

4/23/2025Cheaper Chinese HPV Vaccines Turn Merck's Gardasil From Boom to Bust (...

4/23/2025Global Pharma Feels 'Sense of Urgency' to De-Risk from China Amid Risi...

4/22/2025GemPharmatech Establishes San Diego Facility Amid U.S. Crackdown on Ch...

4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...

4/22/2025China Approves New Indication of Opdivo for NSCLC

4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China

4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...

4/22/2025Fosun Boosts Stake in Henlius After Failed Privatization Attempt

4/22/2025Fujifilm Capitalizes on U.S.-China Tensions with $3B Biopharma Deal

4/22/2025Carbogen Amcis Secures Chinese Drug Manufacturing License

4/22/2025China Broadens Healthcare Access: Foreign Doctors and Drug Import Refo...

4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...

4/19/2025Haleon Achieves Full Ownership of Tianjin SmithKline JV

4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...

4/18/2025WuXi Biologics Completes 15,000L PPQ at Hangzhou Site

4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)

4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...

4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...

Page:9/363 Total number of articles:10881: [First][<<] [7] [8] [9] [10] [11] [>>] [End]